top of page
  • Writer's pictureAbacus Research

Entegris (ENTG): Under-appreciated compounder

Entegris is a chemicals and filtration company that just happens to sell into the semiconductor market. We want to be owners of ENTG as it is high-quality, defensive, and an EPS compounder that will out-grow semi volume growth due to trends of increasing purity and material intensity in semis.

  • We think the benefits from the CMC acquisition could surprise on the upside and is not fully appreciated by the market.

  • Financials are poised to improve: EPS growth will accelerate meaningfully in late 2023 driven by revenue growth, high incremental margins, cost saves, and continue into 2025 as debt is paid down.

Potential Upside: $114 (+31%) Sensible Downside: $70 (-20%)

Recent Posts

See All

Fortive: potential14% IRR

Fortive is a high quality business with an asset light model, high margins, high incremental margins and consistent FCF generation that is reinvested in M&A. Recent guidance for slow organic growth fo

Vertiv (VRT) - Datacentre play on AI theme

Vertiv is a leader in critical infrastructure for datacentres and a clear beneficiary of AI driven growth. AI tailwind for datacentres is only starting. To date, Vertiv has seen little to no impact fr

Palantir (PLTR)

The advent of LLM’s have changed Palantir's relationships with institutions – the commercial market is now open to what Palantir is selling. This is a significant change from one year ago. AIP bootcam


bottom of page